Home LiteratureArticle Details
PMID: 6776529 Published · ppublish English Journal Article

Partial sequence of human complement component factor B: novel type of serine protease.

Christie DL, Gagnon J, Porter RR

Abstract

Factor B (a component of the alternative pathway of complement) is believed to contain the proteolytic site of the complex enzymes C3 convertase (C3bB) and C5 convertase (C3bnB). Conflicting results have been obtained in regard to the inactivation of these enzymes by diisopropyl phosphorofluoridate but it has been suggested that activated Factor B (Factor B) is a serine protease with the active site in Bb, a COOH-terminal fragment of approximately 60,000 molecular weight. Partial amino acid sequence studies of Bb derived from human Factor B have shown that the NH2-terminal 40 residues have no homology with NH2-terminal sequences of other serine proteases. However, positioning of a further 170 residues out of approximately 290 residues in two continuous CNBr fragments from the COOH terminus has shown that there is a strong homology of sequence in this section. The active site residues histidine, aspartic acid, and serine all are present in positions corresponding with those of typical serine proteases. It is suggested that Factor B is a novel type of serine protease with a catalytic chain of molecular weight twice that of proteases previously studied and probably with a different activation mechanism.

MeSH Terms
Amino Acid Sequence Amino Acids/analysis Binding Sites Complement Factor B/metabolism Cyanogen Bromide Enzyme Precursors/metabolism Humans Peptide Fragments Peptide Hydrolases Serine
Chemicals
Amino Acids Enzyme Precursors Peptide Fragments Serine Peptide Hydrolases Complement Factor B Cyanogen Bromide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Christie D L
Gagnon J
Porter R R
References (14)
14 references, click to expand
  1. Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation.
    Biochemistry. 1970 Apr 28;9(9):1997-2009 PMID: 5442169
  2. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  3. Specific cleavage between variable and constant domains of rabbit antibody light chains by dilute acid hydrolysis.
    Biochemistry. 1972 Dec 19;11(26):4974-7 PMID: 4404720
  4. Third component of human complement: purification from plasma and physicochemical characterization.
    Biochemistry. 1976 Oct 5;15(20):4513-21 PMID: 823964
  5. Role of proteolytic enzymes in biological regulation (a review).
    Proc Natl Acad Sci U S A. 1976 Nov;73(11):3825-32 PMID: 1069267
  6. The serine protease nature of the C3 and C5 convertases of the classical and alternative complement pathways.
    Scand J Immunol. 1976;5(9):1049-55 PMID: 1006167
  7. The alternative pathway of complement activation.
    Adv Immunol. 1976;24:1-35 PMID: 798473
  8. Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36.
    Immunochemistry. 1977 Mar;14(3):201-5 PMID: 863465
  9. Sequence of the amino-terminal 349 residues of rabbit muscle glycogen phosphorylase including the sites of covalent and allosteric control.
    Biochemistry. 1978 Dec 26;17(26):5657-72 PMID: 728424
  10. Enzymatic conversion of proteins to glycoproteins by lipid-linked saccharides: a study of potential exogenous acceptor proteins.
    J Supramol Struct. 1978;8(1):51-65 PMID: 732307
  11. Third component of human complement: structural analysis of the polypeptide chains of C3 and C3b.
    Biochemistry. 1979 Apr 17;18(8):1497-503 PMID: 427127
  12. The alternative pathway C3/C5 convertase: chemical basis of factor B activation.
    J Immunol. 1979 Aug;123(2):529-34 PMID: 458145
  13. Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.
    Biochem J. 1979 Dec 1;183(3):615-22 PMID: 261515
  14. Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.
    Biochem J. 1980 Jun 1;187(3):863-74 PMID: 6821372
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1980-08-00
Pages
4923-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC349961
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com